The effect of green coffee supplementation on IL-6 and IL-10 levels in patients with polycystic ovary syndrome.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180808040745N1

Enrollment

Registered

2018-11-08

Start date

2018-09-21

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic Ovary Syndrome. Polycystic ovarian syndrome

Interventions

Intervention 1: Intervention group: green coffee supplement, chlorogenic acid, dose 400 milligram, one tablet a day, 40 days, brand of green coffee supplemet is BSK. Intervention 2: Control group: Pla

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Women with Polycysctic Ovary Syndrome that desire to participate in the research Using Metformin, Clomiphene, Letrozole, HMG and HCG, Folic Acid Age between 20 and 40 BMI between 18.5 and 34.9 kilogram per square meters or more

Exclusion criteria

Exclusion criteria: Deciding to get pregnant during the reaserch Having allergy and being intolerant to green coffee Using nonsteroidal and steroidal anti-inflammatory drugs Having thyroid and kidney disorders Using dietary supplements

Design outcomes

Primary

Measure	Time frame
IL-6 and IL-10 levels in patients with polycystic ovary syndrome. Timepoint: Before and after supplementation. Method of measurement: ELISA test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehrnoush Meshkani

Islamic Azad University

meshkani_meh@yahoo.com+98 51 3601 9405

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026